Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Neuregulin-1: A Tonic for Cardiorenal Syndrome? And All Else That Ails Us?
Journal: JACC. Basic to translational science
Published: October 04, 2023
Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.
Journal: Molecular cancer
Published: June 12, 2021
Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease.
Journal: Clinical science (London, England : 1979)
Published: July 14, 2020
Novel drugs that target the metabolic reprogramming in renal cell cancer.
Journal: Cancer & metabolism
Published: March 28, 2016
Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.
Journal: Molecular cancer
Published: September 11, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026